Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more
Shanghai Runda Med Tech Co (603108) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.028x
Based on the latest financial reports, Shanghai Runda Med Tech Co (603108) has a cash flow conversion efficiency ratio of 0.028x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥144.38 Million) by net assets (CN¥5.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Runda Med Tech Co - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Shanghai Runda Med Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Runda Med Tech Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Runda Med Tech Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Founder Motor Co Ltd
SHE:002196
|
0.025x |
|
Noah Holdings Ltd
NYSE:NOAH
|
0.000x |
|
Shanghai SMI Holding Co Ltd
SHG:600649
|
0.036x |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
0.013x |
|
Transmissora Aliança de Energia Elétrica S.A
SA:TAEE3
|
0.086x |
|
Anhui Shanying Paper Industry Co Ltd
SHG:600567
|
0.044x |
|
Suzhou Sushi Testing Instrument Co Ltd
SHE:300416
|
0.055x |
|
FIRST RESOURCES LTD O.N.
F:5F1
|
N/A |
Annual Cash Flow Conversion Efficiency for Shanghai Runda Med Tech Co (2014–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Runda Med Tech Co from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.60 Billion | CN¥646.95 Million | 0.115x | -13.83% |
| 2023-12-31 | CN¥5.45 Billion | CN¥729.72 Million | 0.134x | +256.49% |
| 2022-12-31 | CN¥5.01 Billion | CN¥-428.86 Million | -0.086x | -201.31% |
| 2021-12-31 | CN¥4.39 Billion | CN¥371.11 Million | 0.084x | +6.59% |
| 2020-12-31 | CN¥4.08 Billion | CN¥323.44 Million | 0.079x | +13.00% |
| 2019-12-31 | CN¥3.52 Billion | CN¥246.68 Million | 0.070x | -59.24% |
| 2018-12-31 | CN¥3.13 Billion | CN¥538.90 Million | 0.172x | +638.52% |
| 2017-12-31 | CN¥2.75 Billion | CN¥-87.85 Million | -0.032x | +43.39% |
| 2016-12-31 | CN¥2.22 Billion | CN¥-125.47 Million | -0.056x | +76.87% |
| 2015-12-31 | CN¥928.55 Million | CN¥-226.69 Million | -0.244x | -421.52% |
| 2014-12-31 | CN¥475.63 Million | CN¥36.11 Million | 0.076x | -- |